{ "company_number": "06784774", "name": "Clark Antibodies Ltd", "url": "/company/06784774", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2009-01-07", "dissolved_on": null, "sic_codes": [ { "code": "70229", "description": "Management consultancy activities other than financial management", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/70229" } ], "registered_address": { "id": 2799449, "url": "/address/2799449", "line1": "10 WELLINGTON STREET", "line2": "", "post_town": "CAMBRIDGE", "county": "", "country": "ENGLAND", "postcode": "CB1 1HW" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06784774", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-02-28", "last_made_up": "2025-05-31", "category": "MICRO ENTITY", "filings": [ { "url": "/company/06784774/accounts/2025-05-31", "made_up_date": "2025-05-31", "period_start": "2025-05-31", "period_end": "2025-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1000000.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "383446.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "386150.00", "total_assets_less_current_liabilities": "1386150.00", "net_assets_liabilities": "1374863.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1374863.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/06784774/accounts/2024-05-31", "made_up_date": "2024-05-31", "period_start": "2024-05-31", "period_end": "2024-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1000000.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "379881.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "382710.00", "total_assets_less_current_liabilities": "1382710.00", "net_assets_liabilities": "1374863.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1374863.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/06784774/accounts/2023-05-31", "made_up_date": "2023-05-31", "period_start": "2023-05-31", "period_end": "2023-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1000000.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "366618.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "368296.00", "total_assets_less_current_liabilities": "1368296.00", "net_assets_liabilities": "1367493.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1367493.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2023.zip" }, { "url": "/company/06784774/accounts/2022-05-31", "made_up_date": "2022-05-31", "period_start": "2022-05-31", "period_end": "2022-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1000136.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "365967.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "366422.00", "total_assets_less_current_liabilities": "1366558.00", "net_assets_liabilities": "1365805.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1365805.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2022.zip" }, { "url": "/company/06784774/accounts/2021-05-31", "made_up_date": "2021-05-31", "period_start": "2021-05-31", "period_end": "2021-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1000656.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "375126.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "375566.00", "total_assets_less_current_liabilities": "1376222.00", "net_assets_liabilities": "1375519.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1375519.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/06784774/accounts/2020-05-31", "made_up_date": "2020-05-31", "period_start": "2020-05-31", "period_end": "2020-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1718.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "1382390.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1382597.00", "total_assets_less_current_liabilities": "1384315.00", "net_assets_liabilities": "1383612.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1383612.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2020.zip" }, { "url": "/company/06784774/accounts/2019-05-31", "made_up_date": "2019-05-31", "period_start": "2019-05-31", "period_end": "2019-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1899.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "1400300.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1385336.00", "total_assets_less_current_liabilities": "1387235.00", "net_assets_liabilities": "1386532.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1386532.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/06784774/accounts/2018-05-31", "made_up_date": "2018-05-31", "period_start": "2018-05-31", "period_end": "2018-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "1637829.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1516261.00", "total_assets_less_current_liabilities": "1516261.00", "net_assets_liabilities": "1515558.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1515558.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2018.zip" }, { "url": "/company/06784774/accounts/2017-05-31", "made_up_date": "2017-05-31", "period_start": "2017-05-31", "period_end": "2017-05-31", "entity_name": "Clark Antibodies Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "1208464.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1094180.00", "total_assets_less_current_liabilities": "1094180.00", "net_assets_liabilities": "1093477.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1093477.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/06784774/accounts/2016-05-31", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Clark Antibodies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "36.00", "debtors": "1056.00", "cash_bank_in_hand": "883872.00", "current_assets": "884928.00", "creditors_due_within_one_year": "83879.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "801049.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "801085.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "801083.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/06784774/accounts/2015-05-31", "made_up_date": "2015-05-31", "period_start": "2015-05-31", "period_end": "2015-05-31", "entity_name": "Clark Antibodies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "72.00", "debtors": "68505.00", "cash_bank_in_hand": "541496.00", "current_assets": "610001.00", "creditors_due_within_one_year": "31219.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "578782.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "578854.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "578852.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2015.zip" }, { "url": "/company/06784774/accounts/2014-05-31", "made_up_date": "2014-05-31", "period_start": "2014-05-31", "period_end": "2014-05-31", "entity_name": "Clark Antibodies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "2125.00", "cash_bank_in_hand": "482534.00", "current_assets": "484659.00", "creditors_due_within_one_year": "3674.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "480985.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "480985.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "480983.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2014.zip" }, { "url": "/company/06784774/accounts/2013-05-31", "made_up_date": "2013-05-31", "period_start": "2013-05-31", "period_end": "2013-05-31", "entity_name": "Clark Antibodies Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "2923.00", "cash_bank_in_hand": "501410.00", "current_assets": "504333.00", "creditors_due_within_one_year": "34956.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "469377.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "470644.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "470642.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2014.zip" } ], "pdf_only_filings": [ { "made_up_date": "2013-01-31", "filing_date": "2013-03-18", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06784774/accounts/2013-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06784774/filing-history/MzA3NDYzNzI0MmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2012-01-31", "filing_date": "2012-03-23", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06784774/accounts/2012-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06784774/filing-history/MzA1NDY0MjA1NWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2011-01-31", "filing_date": "2011-03-09", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06784774/accounts/2011-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06784774/filing-history/MzAzMzU1MDAzOWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2010-01-31", "filing_date": "2010-05-04", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06784774/accounts/2010-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06784774/filing-history/MzAxNDc3NTQ4MmFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06784774/filing-history" }, "confirmation_statement": { "next_due": "2027-01-16", "last_made_up": "2026-01-02" }, "officers": [], "psc": [ { "name": "Clark Bradbury Ltd", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/06784784", "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T04:59:58.547413+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }